LB Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Nov '25 Nov 19, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	402	-	-	-
Enterprise Value	91	-	-	-
Debt / Equity Ratio	0.01	0.19	-	-1.12
Quick Ratio	47.31	3.45	16.61	45.64
Current Ratio	47.60	3.56	17.51	45.82
Return on Equity (ROE)	-	-206.22%	-63.14%	-
Return on Assets (ROA)	-	-102.33%	-21.18%	-
Return on Capital (ROIC)	-	-124.86%	-32.30%	-
Return on Capital Employed (ROCE)	-7.00%	-255.00%	-26.40%	-13.40%
Buyback Yield / Dilution	-10035.57%	-0.87%	-8.02%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q